The Theoretical Ecology Lab Teas are designed to be informal meetings for members of the research groups of Simon Levin, Steve Pacala, Henry Horn, and Andy Dobson to give talks on their current research and receive feedback from their audience. The talks are usually 30 minutes, including the question and answer sessions, scheduled on Wednesdays at 1.30 PM. Additionally, other members of the Princeton University community and visitors are welcome to attend and to give presentations.
Talk schedules and email lists are maintained
by Adrian de Froment and Jeanne DeNoyer. Please contact
adriande[at]princeton[dot]edu or jdenoyer[at]princeton[dot]edu to have your
name added to the labtea email list so that you can receive reminders about
upcoming lab teas.
To view previous schedules and summaries, go
to:
Fall
2002 Spring
2003
Fall
2003 Spring
2004
Fall
2004 Spring
2005
Fall
2005 Spring
2006 Summer
2006
Fall
2006 Spring
2007
Fall
2007
To view the latest schedule, click here.
Spring
2008
Wednesday February 6th at 1.30pm |
Parviez Hosseini |
Wednesday February 13th at 1.30pm |
Wilfred Ndifon |
Wednesday February 20th at 1.30pm |
Eili Klein |
Wednesday February 27th at 1.30pm |
no labtea - lunch for visiting speaker in Eno 209 |
Wednesday March 5th at 1.30pm |
Ryan Chisholm |
Wednesday March 12th at 1.30pm |
Bethany Bradley |
Wednesday March 19th at 1.30pm |
|
Wednesday March 26th at 1.30pm |
Blake Suttle |
Wednesday April 2nd at 1.30pm |
Yude Pan |
Wednesday April 9th at 1.30pm |
Ryan Chisholm |
Wednesday April 16th at 1.30pm |
|
Wednesday April 23rd at 1.30pm |
|
Wednesday April 30th at 1.30pm |
Michael Desai |
Wednesday May 7th at 1.30pm |
Liliana Salvador |
Wednesday May 14th at 1.30pm |
Michael Raghib |
Wednesday May 21st at 1.30pm |
Ray Dybzinski |
Titles and abstracts (posted approximately one week before the
talk):
Parviez Hosseini
Disease in a Community Context: Pathogen-induced reversal of native dominance in California grasslands.
Wilfred Ndifon
On the use of hemagglutination-inhibition for influenza surveillance: some theoretical considerations and implications for quantifying influenza virus’ antigenic evolution
The World Health Organization’s global influenza surveillance program routinely uses data obtained by means of the hemagglutination-inhibition (HI) assay to inform the prediction of influenza viruses that will be prevalent (or dominant) in future influenza seasons. The program has been fairly successful in predicting dominant influenza viruses with epidemic potential. However, there have been a number of failures that could have had devastating consequences if the missed dominant viruses had pandemic potential. In order to reduce the chances of such failures, there is great need for improvement in the interpretation of HI data. To that end, the kinetics of HI was investigated theoretically and a mathematical equation that illuminates the dependence of HI data on the values of key experimental parameters (e.g., the concentration of virus and the avidity of antibody for virus) was derived. The derived equation predicts, among other things, that the most commonly-used HI-based method of quantifying influenza virus’ antigenic evolution, namely the normalized heterologous HI titer (NHT), depends on non antigenically-relevant experimental parameters, much more so than does the Archetti-Horsfall method (AHM). This prediction is in line with previous empirical evidence and it suggests that the AHM should be the preferred method of quantifying influenza virus’ antigenic evolution. When applied to HI data on the antigenic evolution of influenza viruses during the period from 1933 to 2006, both the AHM and the NHT predict statistical patterns of antigenic evolution that are qualitatively similar on short time scales, but different on longer time scales.
Eili Klein
Hospital-acquired infections with Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA) infections, are a major cause of illness and death and impose serious economic costs on patients and hospitals. I will discuss the recent magnitude and trend of these infections, as well as policy problems and options in controlling the emergence and spread of new resistant infections
Ryan Chisholm
Bethany Bradley
>
Last updated 2nd January 2008
adriande[at]princeton[dot]edu